GKSL173.89

Gujarat Kidney And Super Speciality Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,371 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
GKSL
FY26
GPTHEALTH
FY26
SHALBY
FY26
INDRAMEDCO
FY26
Peer
Median
Valuation — at last close
P/E69.84×31.27×44.97×18.00×31.27× +123%
P/B5.38×4.90×1.55×4.46×4.46× +21%
EV/EBITDA50.98×15.33×14.13×12.36×14.13× +261%
Market Cap₹1,371 Cr₹1,322 Cr₹1,562 Cr₹3,305 Cr₹1,562 Cr -12%
Growth
Revenue CAGR 3Y12.35%10.50%11.43%
Revenue CAGR 5Y19.30%19.30%
Net Income CAGR 3Y-19.97%28.69%4.36%
Revenue YoY (latest Q)17.83%11.74%11.26%11.74%
Net Income YoY (latest Q)65.73%36.70%8.53%36.70%
Profitability
EBITDA Margin32.85%17.81%12.51%18.00%17.81% +84%
Net Income Margin20.50%8.93%3.04%12.39%8.93% +130%
Return on Common Equity6.08%15.67%3.72%24.80%15.67% -61%
Return on Capital Employed8.24%14.82%5.76%27.17%14.82% -44%
Return on Assets5.65%9.08%1.89%18.52%9.08% -38%
Credit & Quality
Total Debt/Equity0.06×0.06×0.54×0.00×0.06× +0%
Interest Coverage11.84×6.93×1.87×37.09×6.93× +71%
Scale — latest FY
Revenue / Total Income₹82 Cr₹473 Cr₹1,141 Cr₹1,483 Cr₹1,141 Cr -93%
Net Income₹16.8 Cr₹42.2 Cr₹34.7 Cr₹184 Cr₹42.2 Cr -60%
Total Assets₹298 Cr₹465 Cr₹1,839 Cr₹991 Cr₹991 Cr -70%
EPS₹2.49₹5.15₹3.23₹20.03₹5.15 -52%
Book Value per Share₹32.31₹32.84₹93.54₹80.76₹80.76 -60%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.